Health ❯ Healthcare ❯ Regulatory Agencies

FDA

Drug Approval Process Recalls Vaccine Approval Process Drug Warnings Product Recalls Leadership Changes Drug Approval Processes Drug Recalls Drug Approvals Drug Approval Drug Safety Drug Evaluation Emergency Use Authorization Vaccine Recommendations Enforcement Actions Post-Marketing Surveillance Safety Guidelines Preservatives in Vaccines Center for Biologics Evaluation and Research Drug Labeling Vaccine Warnings Approval Process Recall Notices Adverse Event Reporting Leadership Decisions Safety Communications Food Recalls Medication Shortage Database Drug Shortage Declarations Drug Monitoring Recall Classifications Workforce Issues Biologics License Applications Drug Safety Guidelines FDA Recalls Vaccine Regulation Mammography Quality Standards Act Product Safety FDA Commissioner Emergency Declarations Public Health Initiatives Mifepristone Warning Letters Product Warnings Drug Enforcement Public Health Alerts Transparency Initiatives Public Health Regulation Import Alerts Drug Rejection Public Health Policy Drug Safety Reviews Vaccine Licensing Product Safety Alerts Vaccine Oversight Accelerated Approval Pathways Recalls and Alerts Warnings and Advisories

FDA Elevates Nationwide Cough-Drop Recall to Class II

The rating signals possible short-term, reversible health effects.

FDA Flags Recall of 3.1 Million Store-Brand Eye Drops Over Sterility Concerns

3.1 Million Bottles of Store-Brand Eye Drops Recalled for Sterility Concerns

FDA Flags 76 Liver Injuries Linked to Amgen’s Tavneos, Urges Tight Monitoring

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

FDA Recalls Specific FreeStyle Libre 3 Sensors Over Faulty Low-Glucose Readings

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

MediNatura Recalls All ReBoost and ClearLife Nasal Sprays Over Contamination Risk

FDA Names Tracy Beth Høeg Acting CDER Director as OTC Drugs Chief Is Reassigned

Walgreens Recalls Saline Nasal Spray After FDA Flags Bacterial Contamination

FDA Drops Broad Black-Box Warnings on Menopause Hormone Therapy

FDA Issues Warning Letters to 18 Websites Selling Unapproved Botox-Like Injectables

FDA Issues Safety Alert on RF Microneedling Injuries

Teva, Amerisource Pull 580,000+ Prazosin Bottles as FDA Flags Nitrosamine Contamination

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Signals Openness to Accelerated Path for Lexeo’s Friedreich’s Ataxia Cardiac Gene Therapy

FDA Approves Palsonify, First Once-Daily Oral Treatment for Acromegaly

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

HHS Removes Thimerosal From All U.S. Flu Vaccines Ahead of 2025-26 Season

FDA Begins Expert Review of Menopause Hormone Therapy Warnings